StonvexLoading…
StonvexStonvexStonvexCore line items from EPAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.40B | $5.46B | $4.05B | $2.66B |
Operating Income | $116.77M | $520.00M | $370.75M | $225.81M |
Net Income | $82.52M | $377.68M | $268.32M | $88.03M |
EPS (Diluted) | $1.52 | $6.72 | $4.75 | $2.84 |
Total Assets | $4.70B | $4.90B | $4.84B | $4.71B |
Total Liabilities | $1.27B | $1.22B | $1.12B | $1.04B |
Cash & Equivalents | $1.04B | $1.30B | $1.24B | $1.04B |
Free Cash Flow OCF − CapEx | $-54.22M | $612.69M | $344.58M | $58.20M |
Shares Outstanding | 52.76M | 54.27M | 55.21M | 55.70M |